The following NIH funding opportunities have been brought to our attention. These may be applicable to research using NHLBI Biorepository and/or Data Repository resources.
These funding opportunities are not administered by the BioLINCC program. Inquiries regarding research topic eligibility and other administrative matters should be directed to the staff offices identified in the announcements. However, BioLINCC staff will be pleased to provide assistance if needed to search for suitable repository resources for the proposed research. To search for studies or submit a request for resources available through BioLINCC, follow the instructions on the Studies page.
RFA-HL-17-022 Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21)
The purpose of this Funding Opportunity Announcement (FOA) is to support meritorious exploratory research relevant to the NHLBI mission using the existing biospecimen collections that are stored in the NHLBI Biorepository and that are available through the BioLINCC website. The goals of the RFA are to maximize the scientific value of the stored collections and provide researchers with an opportunity to generate preliminary data for subsequent research proposals.
The specific aims must include the use of biospecimens stored in the NHLBI Biorepository from a collection(s) identified on the BioLINCC website as an "Open BioLINCC Study". A Letter of Availability from BioLINCC that confirms the availability of biospecimens for the proposed research aims must be included. Resubmitted applications must obtain a new Letter of Availability from BioLINCC. Applications without a current Letter of Availability will be considered incomplete and will not be reviewed.
For more information on RFA-HL-17-022 please visit:
For FAQs about RFA-HL-17-022, please visit:
PAR-17-004 Secondary Dataset Analyses in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)
The goal of this funding opportunity is to stimulate the use of existing human datasets for well-focused secondary analyses to investigate novel scientific ideas or new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the NHLBI mission. This FOA actively supports the use of existing database resources to conduct additional analyses secondary to a project's originally-intended primary purpose. Applications may be related to, but must be distinct from, the specific aims of the original data collection; it will not support the collection of new data.
For more information on PAR-17-004 please visit:
PA-15-169 Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21)
This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic diseases including thyroid, parathyroid and Cushing's diseases and acromegaly; and genetic metabolic disease including cystic fibrosis, lysosomal storage diseases, and disorders of the urea cycle, amino acid metabolism and metal transport where the focus is on peripheral metabolism or organ function; obesity, liver diseases, alimentary GI tract diseases and nutrition; kidney, urologic, and hematologic diseases. The goal of this program is to facilitate research that explores innovative hypotheses through the use of existing data sets.
For more information on PA-15-169 please visit: